AI assistant
DEXCOM INC — Director's Dealing 2022
May 23, 2022
30198_dirs_2022-05-23_0dcc8988-c46b-4c41-be99-52f4267466d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2022-05-20
Reporting Person: Heller Bridgette P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-20 | Common Stock | A | 988 | $0.001 | Acquired | 5355 | Direct |
Footnotes
F1: The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2: Included in this number are 2,000 unvested restricted stock units, 988 of which were granted on May 20, 2022 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2023 Annual Meeting and 1,012 of which were granted on September 13, 2019 and shall vest through September 13, 2022.